Taro Company Profile

✉ Email this page to a colleague

TARO has two hundred and fifty-three approved drugs.

There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.

There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-three supplementary protection certificates in fourteen countries.

International Patents:	31
US Patents:	8
Tradenames:	133
Ingredients:	116
NDAs:	253
Patent Litigation for Taro:	See patent lawsuits for Taro
PTAB Cases with Taro as petitioner:	See PTAB cases with Taro as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	IVERMECTIN	ivermectin	LOTION;TOPICAL	210720-001	May 6, 2020		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	ACETIC ACID	acetic acid, glacial	SOLUTION/DROPS;OTIC	088638-001	Sep 6, 1984	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro Pharm Inds	ETODOLAC	etodolac	TABLET;ORAL	075074-002	Apr 25, 2000	AB	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Taro Pharm Inds	CARBAMAZEPINE	carbamazepine	TABLET, CHEWABLE;ORAL	075687-002	Jul 29, 2002		RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Taro	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040301-004	Jul 15, 1999	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,656,482	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	5,881,926	⤷ Try a Trial
Taro	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	5,990,100	⤷ Try a Trial
Taro	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	5,919,479	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,071,523	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18
➤ Subscribe	Topical Lotion	0.5%	➤ Subscribe	2011-03-16

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
China	102834096	⤷ Try a Trial
New Zealand	566117	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2011088333	⤷ Try a Trial
Canada	2822220	⤷ Try a Trial
South Korea	20080044245	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1458369	132008901685368	Italy	⤷ Try a Trial	PRODUCT NAME: ADAPALENE E BENZOILE PEROSSIDO(EPIDUO); AUTHORISATION NUMBER(S) AND DATE(S): 40440, 20071218;DA 038261018/M A 038261057/M, 20080618
3347352	2290051-8	Sweden	⤷ Try a Trial	PRODUCT NAME: LENACAPAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR LENACAPAVIR SODIUM; REG. NO/DATE: EU/1/22/1671 20220819
1586316	122011100019	Germany	⤷ Try a Trial	PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518
2506844	18C1022	France	⤷ Try a Trial	PRODUCT NAME: COMBINAISON COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (EN PARTICULIER LE BROMURE D'UMECLIDINIUM), DU VILANTEROL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (EN PARTICULIER LE TRIFENATATE DE VILANTEROL), ET DU FUROATE DE FLUTICASONE; REGISTRATION NO/DATE: EU/1/17/1236 20171117
1856135	CA 2020 00018	Denmark	⤷ Try a Trial	PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.